Suppr超能文献

携带CTLA-4(CD152)突变患者的免疫缺陷与自身免疫

Immune deficiency and autoimmunity in patients with CTLA-4 (CD152) mutations.

作者信息

Verma N, Burns S O, Walker L S K, Sansom D M

机构信息

Clinical Immunology Department, Royal Free Hospital, London, UK.

Division of Infection and Immunity, School of Life and Medical Sciences, Institute of Immunity and Transplantation, University College London, Royal Free Hospital, London, UK.

出版信息

Clin Exp Immunol. 2017 Oct;190(1):1-7. doi: 10.1111/cei.12997. Epub 2017 Jul 21.

Abstract

Immune deficiency disorders are a heterogeneous group of diseases of variable genetic aetiology. While the hallmark of immunodeficiency is susceptibility to infection, it is increasingly clear that autoimmunity is prevalent, suggestive of a more general immune dysregulation in some cases. With the increasing use of genetic technologies, the underlying causes of immune dysregulation are beginning to emerge. Here we provide a review of the heterozygous mutations found in the immune checkpoint protein CTLA-4, identified in cases of common variable immunodeficiency disorders (CVID) with accompanying autoimmunity. Study of these mutations provides insights into the biology of CTLA-4 as well as suggesting approaches for rational treatment of these patients.

摘要

免疫缺陷疾病是一组病因各异的遗传性疾病。虽然免疫缺陷的标志是易受感染,但越来越明显的是,自身免疫现象普遍存在,这表明在某些情况下存在更普遍的免疫失调。随着基因技术的日益应用,免疫失调的潜在原因开始显现。在此,我们综述了在伴有自身免疫的常见可变免疫缺陷疾病(CVID)病例中发现的免疫检查点蛋白CTLA-4中的杂合突变。对这些突变的研究为CTLA-4的生物学特性提供了见解,并为合理治疗这些患者提出了方法。

相似文献

1
Immune deficiency and autoimmunity in patients with CTLA-4 (CD152) mutations.
Clin Exp Immunol. 2017 Oct;190(1):1-7. doi: 10.1111/cei.12997. Epub 2017 Jul 21.
3
Disorders of CTLA-4 expression, how they lead to CVID and dysregulated immune responses.
Curr Opin Allergy Clin Immunol. 2019 Dec;19(6):578-585. doi: 10.1097/ACI.0000000000000590.
5
What did we learn from CTLA-4 insufficiency on the human immune system?
Immunol Rev. 2019 Jan;287(1):33-49. doi: 10.1111/imr.12721.
6
The autoimmune conundrum in common variable immunodeficiency disorders.
Curr Opin Allergy Clin Immunol. 2015 Dec;15(6):514-24. doi: 10.1097/ACI.0000000000000218.
7
Lessons from CTLA-4 deficiency and checkpoint inhibition.
Curr Opin Immunol. 2017 Dec;49:14-19. doi: 10.1016/j.coi.2017.07.014. Epub 2017 Aug 11.
8
Evaluation of Expression of LRBA and CTLA-4 Proteins in Common Variable Immunodeficiency Patients.
Immunol Invest. 2022 Feb;51(2):381-394. doi: 10.1080/08820139.2020.1833029. Epub 2020 Nov 15.

引用本文的文献

1
Exploring molecular imaging to investigate immune checkpoint inhibitor-related toxicity.
J Immunother Cancer. 2025 May 7;13(5):e011009. doi: 10.1136/jitc-2024-011009.
2
Correlation between , , and Relative Gene Expressions and Oral Squamous Cell Carcinoma.
J Dent (Shiraz). 2025 Mar 1;26(1):25-32. doi: 10.30476/dentjods.2024.100237.2205. eCollection 2025 Mar.
3
Severe atopic dermatitis treated with Dupilumab in a CTLA-4-deficient patient: A case report and review of the literature.
SAGE Open Med Case Rep. 2025 Jan 7;13:2050313X241311042. doi: 10.1177/2050313X241311042. eCollection 2025.
7
Treg in inborn errors of immunity: gaps, knowns and future perspectives.
Front Immunol. 2024 Jan 8;14:1278759. doi: 10.3389/fimmu.2023.1278759. eCollection 2023.
9
Immune checkpoints in rheumatoid arthritis: progress and promise.
Front Immunol. 2023 Nov 24;14:1285554. doi: 10.3389/fimmu.2023.1285554. eCollection 2023.
10
DECTIN-1: A modifier protein in CTLA-4 haploinsufficiency.
Sci Adv. 2023 Dec 8;9(49):eadi9566. doi: 10.1126/sciadv.adi9566. Epub 2023 Dec 6.

本文引用的文献

1
Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations.
Blood. 2017 Mar 16;129(11):1458-1468. doi: 10.1182/blood-2016-10-745174. Epub 2017 Feb 3.
2
Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis.
J Allergy Clin Immunol. 2017 Mar;139(3):1043-1046.e5. doi: 10.1016/j.jaci.2016.08.042. Epub 2016 Nov 28.
3
Assessment of CTLA-4 Deficiency-Related Autoimmune Choroidopathy Response to Abatacept.
JAMA Ophthalmol. 2016 Jul 1;134(7):844-6. doi: 10.1001/jamaophthalmol.2016.1013.
4
Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.
Immunity. 2016 May 17;44(5):955-72. doi: 10.1016/j.immuni.2016.05.002.
5
Hematopoietic stem cell transplantation for CTLA4 deficiency.
J Allergy Clin Immunol. 2016 Aug;138(2):615-619.e1. doi: 10.1016/j.jaci.2016.01.045. Epub 2016 Apr 18.
7
A Patient with CTLA-4 Haploinsufficiency Presenting Gastric Cancer.
J Clin Immunol. 2016 Jan;36(1):28-32. doi: 10.1007/s10875-015-0221-x. Epub 2015 Dec 8.
8
Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4.
J Allergy Clin Immunol. 2016 Jan;137(1):327-330. doi: 10.1016/j.jaci.2015.08.036. Epub 2015 Oct 21.
10
The future of immune checkpoint therapy.
Science. 2015 Apr 3;348(6230):56-61. doi: 10.1126/science.aaa8172.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验